Role of sex and sex steroids in mediating pituitary-adrenal responses to acute buspirone treatment in sheep.
Systematic characterisation of sex differences in the serotonergic modulation of the hypothalamic-pituitary-adrenal (HPA) axis may assist with our understanding of why stress-related disorders are disproportionately represented in women. In this study, we examined the acute effects of buspirone, a serotonergic 1A receptor subtype agonist, on the endocrine endpoints of adrenocorticotrophin (ACTH) and cortisol secretion in gonadectomised male and female sheep. Each sheep was treated with an acute i.v. injection containing vehicle or buspirone (0.03, 0.1 and 0.3 mg/kg) in the presence and absence of sex steroid replacement (SSR). In males, SSR treatment consisted of testosterone (2 x 200 mg s.c. pellets) and, in females, the mid-luteal phase of the oestrus cycle was simulated by treatment with oestradiol (1 cm s.c. implant) and an intravaginal controlled internal drug release device containing 0.3 g progesterone. ACTH, cortisol, testosterone and progesterone were measured in jugular blood. Basal ACTH levels were higher in males, whereas basal cortisol levels were higher in females, regardless of sex steroid status. The magnitude of the increase in ACTH and cortisol secretion following buspirone treatment was dose-dependent. There were no differences in the ACTH responses of males and females to buspirone treatment, either in the presence or absence of sex steroid replacement. However, although the cortisol response to buspirone was greater in females, there was no discernable effect of sex steroid status in addition to this sex difference on either basal or buspirone-stimulated cortisol release. We conclude that the larger basal and buspirone-stimulated cortisol response measured in females may reflect a sex difference, either in the sensitivity of the adrenal gland to ACTH or in the catecholaminergic innervation of the adrenal gland. The lack of effect of sex and sex steroids in the ACTH secretory response to buspirone may indicate that the sex differences in serotonergic modulation of the HPA axis, as reported previously by our group, were mediated via serotonergic receptor subtypes other than the 1A receptor.
Broadbear
J H
JH
Department of Physiology, Monash University, Clayton, Victoria, Australia. jillian.broadbear@med.monash.edu
Pierce
B N
BN
Clarke
I J
IJ
Canny
B J
BJ
D000324:Adrenocorticotropic Hormone / Q000097:blood; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002065:Buspirone / Q000494:pharmacology*; D004967:Estrogens / Q000097:blood / Q000494:pharmacology; D005260:Female; D012739:Gonadal Steroid Hormones / Q000097:blood* / Q000494:pharmacology; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D009919:Orchiectomy; D010052:Ovariectomy; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000502:physiology; D011374:Progesterone / Q000097:blood / Q000494:pharmacology; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*; D012727:Sex Characteristics; D012756:Sheep; D013739:Testosterone / Q000097:blood / Q000494:pharmacology
D004967:Estrogens; D012739:Gonadal Steroid Hormones; D017366:Serotonin Receptor Agonists; D013739:Testosterone; D011374:Progesterone; D000324:Adrenocorticotropic Hormone; D002065:Buspirone; D006854:Hydrocortisone